Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.34 USD | +0.86% | +0.43% | +1.30% |
05-15 | Compugen Names David Silberman CFO | MT |
05-09 | Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ORAMED PHARMACEUTICALS INC. | Other Biotechnology & Medical Research | +0.86% | +0.43% | +1.30% | -47.65% | -19.03% | 94.26M |
- Stock Market
- Equities
- ORMP Stock
- Charts Oramed Pharmaceuticals Inc.
- Relative Strength Chart